Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 821

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy

Open access
Salanova, Vicenta, Witt, Thomas, Worth, Robert, Henry, Thomas R., Gross, Robert E., Nazzaro, Jules M., Labar, Douglas, Sperling, Michael R., Sharan, Ashwini, Sandok, Evan, Handforth, Adrian, Stern, John M., Chung, Steve, Henderson, Jaimie M., French, Jacqueline, Baltuch, Gordon, Rosenfeld, William E., Garcia, Paul, Barbaro, Nicholas M., Fountain, Nathan B., Elias, W. Jeffrey, Goodman, Robert R., Pollard, John R., Tröster, Alexander I., Irwin, Christopher P., Lambrecht, Kristin, Graves, Nina, Fisher, Robert, For the SANTE Study Group, Epstein, Charles, King, Jeanne, Osorio, Ivan, Bakay, Roy, Bergen, Donna·2015·Neurology

Abstract

OBJECTIVE: To report long-term efficacy and safety results of the SANTE trial investigating deep brain stimulation of the anterior nucleus of the thalamus (ANT) for treatment of localization-related epilepsy. METHODS: This long-term follow-up is a continuation of a previously reported trial of 5- vs 0-V ANT stimulation. Long-term follow-up began 13 months after device implantation with stimulation parameters adjusted at the investigators' discretion. Seizure frequency was determined using daily seizure diaries. RESULTS: The median percent seizure reduction from baseline at 1 year was 41%, and 69% at 5 years. The responder rate (≥50% reduction in seizure frequency) at 1 year was 43%, and 68% at 5 years. In the 5 years of follow-up, 16% of subjects were seizure-free for at least 6 months. There were no reported unanticipated adverse device effects or symptomatic intracranial hemorrhages. The Liverpool Seizure Severity Scale and 31-item Quality of Life in Epilepsy measure showed statistically significant improvement over baseline by 1 year and at 5 years (p < 0.001). CONCLUSION: Long-term follow-up of ANT deep brain stimulation showed sustained efficacy and safety in a treatment-resistant population. CLASSIFICATION OF EVIDENCE: This long-term follow-up provides Class IV evidence that for patients with drug-resistant partial epilepsy, anterior thalamic stimulation is associated with a 69% reduction in seizure frequency and a 34% serious device-related adverse event rate at 5 years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000001334

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 821

Metadata

Authors
Salanova, V., Witt, T., Worth, R., Henry, T. R., Gross, R. E., Nazzaro, J. M., Labar, D., Sperling, M. R., Sharan, A., Sandok, E., Handforth, A., Stern, J. M., Chung, S., Henderson, J. M., French, J., Baltuch, G., Rosenfeld, W. E., Garcia, P., Barbaro, N. M., Fountain, N. B., Elias, W. J., Goodman, R. R., Pollard, J. R., Tröster, A. I., Irwin, C. P., Lambrecht, K., Graves, N., Fisher, R., For the SANTE Study Group, Epstein, C., King, J., Osorio, I., Bakay, R., & Bergen, D.
Venue
Neurology
Published
2015-03-10
Volume
84
Issue
10
Pages
1017-1025
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2158334924
Cited by
821
References
16
FWCI
34.62
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. https://app.cochat.ai/papers/10.1212/wnl.0000000000001334
The paper
Salanova, V., Witt, T., Worth, R., Henry, T. R., Gross, R. E., Nazzaro, J. M., Labar, D., Sperling, M. R., Sharan, A., Sandok, E., Handforth, A., Stern, J. M., Chung, S., Henderson, J. M., French, J., Baltuch, G., Rosenfeld, W. E., Garcia, P., Barbaro, N. M., . . . Bergen, D. (2015). Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology. https://doi.org/10.1212/wnl.0000000000001334

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.